4.5 Review

MicroRNAs in cancer: Glioblastoma and glioblastoma cancer stem cells

Journal

NEUROCHEMISTRY INTERNATIONAL
Volume 77, Issue -, Pages 68-77

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuint.2014.06.002

Keywords

Cancer; Cancer stem cells; Glioblastoma; Glioma; MicroRNA

Funding

  1. HEAD-RUSH Brain Tumor Research Professorship
  2. Roger Loff Memorial Fund for GBM Research
  3. NIH [R21CA161704, R01NS075995, R01CA158800]

Ask authors/readers for more resources

MicroRNAs represent an abundant class of endogenously expressed 18-25 nucleotide non-coding RNA molecules that function to silence gene expression through a process of post-transcriptional modification. They exhibit varied and widespread functions during normal development and tissue homeostasis, and accordingly their dysregulation plays major roles in many cancer types. Gliomas are cancers arising from the central nervous system. The most malignant and common glioma is glioblastoma multiforme (GBM), and even with aggressive treatment (surgical resection, chemotherapy, and radiation), average patient survival remains less than 2 years. In this review we will summarize the current findings regarding microRNAs in GBM and the biological and clinical implications of this data. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available